NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

AI支援醫療影像解決方案的全球市場:2020-2030年

Global AI-Enabled Medical Imaging Solutions Market: 15 Countries Analysis - Analysis and Forecast, 2020-2030

出版商 BIS Research Inc. 商品編碼 982281
出版日期 內容資訊 英文 314 Pages
商品交期: 最快1-2個工作天內
價格
AI支援醫療影像解決方案的全球市場:2020-2030年 Global AI-Enabled Medical Imaging Solutions Market: 15 Countries Analysis - Analysis and Forecast, 2020-2030
出版日期: 2020年12月24日內容資訊: 英文 314 Pages
簡介

全球AI支援醫療影像解決方案的市場規模在預測期間內預計以26.69%的年複合成長率發展,從2019年的6億3610萬美元,2030年101億4510萬美元的規模。臨床性決策複雜增加,放射線科醫生的工作負擔增加,大規模的R&D投資等要素,促進該市場的成長。同時,對AI等的先進技術引進的醫生消極態度,醫療資料相關的隱私及安全上的疑慮等的課題預計妨礙市場進一步成長。

本報告提供全球AI支援醫療影像解決方案的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,相關法律,RWE (現實世界證據),市場規模的變化、預測,模式、產品、部署模型、工作流程、診療科、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

摘要整理

第1章 產品定義

第2章 調查範圍

第3章 調查手法

第4章 產業考察

  • 產業生態系統
  • 法律上的必要條件、規定
  • COVID-19的影響

第5章 RWE (現實世界evidence)

  • 概要
  • Aidoc
  • Arterys Inc.
  • Bay Labs, Inc.
  • Heart Flow, Inc.
  • MIRADA MEDICAL LIMITED
  • RADLogics Inc.
  • VIDA Diagnostics, Inc.
  • VUNO Inc.
  • Zebra Medical Vision, Inc.

第6章 市場情境

  • 假設、規定
  • 全球市場情境
  • 潛在的市場機會
  • 市場動態
    • 影響分析
    • 市場推動因素
    • 市場抑制因素

第7章 競爭情形

  • 主要策略、展開
  • 成長佔有率分析

第8章 市場分析、預測:各種模式

  • 概要
  • CT
  • MR
  • 超音波
  • X光
  • 乳房X光攝影
  • 多重模式成像系統
  • 其他

第9章 市場分析、預測:各產品

  • 概要
  • 軟體
    • 永久軟體許可證
    • 訂閱軟體許可證
    • 每案例費用的軟體許可證
  • 硬體設備

第10章 市場分析、預測:各部署模型

  • 概要
  • 雲端基礎、Web為基礎
  • 內部部署

第11章 市場分析、預測:各工作流程

  • 概要
  • 影像取得
  • 影像分析
  • 檢測
  • 診斷、治療的決策支援
  • 預測分析與風險評估
  • 分診
  • 匯報、通訊

第12章 市場分析、預測:各診療科

  • 概要
  • 特殊影像
    • 心臟
    • 腫瘤
    • 神經
    • 呼吸系統
    • 整形外科
    • 其他
  • 一般影像

第13章 市場分析、預測:各地區、主要國家

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第14章 企業簡介

  • Agfa-Gevaert Group
  • Butterfly Network, Inc.
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hyperfine
  • Hologic, Inc.
  • Koninklije Philips N.V.
  • Nanox
  • Siemens Healthineers AG
  • Aidoc
  • Arterys Inc.
  • Beijing Infervision Technology Co., Ltd.
  • Blackford Analysis Limited
  • Eureka Clinical AI, formerly known as EnvoyAI
  • iCAD, Inc.
  • MIRADA MEDICAL LIMITED
  • Nuance Communications, Inc.
  • NVIDIA Corporation
  • Synopsys, Inc.
  • VUNO lnc.
  • Zebra Medical Vision, Inc.
目錄
Product Code: BHR0750SB

"Global AI-Enabled Medical Imaging Solutions Market to Reach $10.15 Billion by 2030."

Market Report Coverage - AI-Enabled Medical Imaging Solutions

Market Segmentation

  • Therapeutic Application - Cardiology, Oncology (Breast, Lung, Other Cancer Types), Neurology, Respiratory, Orthopedic, and Others
  • Modality- CT, MRI, X-Ray, Ultrasound, PET, Other Modalities
  • Workflow- Image Acquisition, Image Analysis, Detection, Diagnosis, and Treatment Decision Support, Predictive Analysis & Risk Assessment, Triage, Reporting and Communication, and Equipment Maintenance

Regional Segmentation

  • North America- U.S. and Canada
  • Europe- Germany, U.K, Italy, Spain, France, Switzerland, Sweden, Netherlands, and Rest-of-Europe
  • Asia-Pacific- Japan, China, South Korea, Australia and New Zealand, Singapore, and Rest-of-Asia-Pacific
  • Rest-of-the-World

Growth Drivers

  • Increasing Complexities of Clinical Decision-Making
  • Expanding Range of Applications
  • Shortage of Healthcare Workforce
  • Huge R&D investment

Market Challenges

  • Privacy and Security Concerns Related to Healthcare Data
  • Regulatory Challenges
  • Barriers to Physician's Adoption of AI
  • Lag in Regulatory Approvals
  • Legal Implications of AI Systems
  • Rise in Medical Imaging Expenses
  • Data Security and Privacy Issues
  • Lack of Trained Staff

Market Opportunities

  • Rapidly Evolving Deep Learning Techniques
  • Increasing Number of Cross-Industry Partnerships

Key Companies Profiled:

Siemens Healthineers AG., General Electric Company, Agfa- Gevart Group, Hologic, Inc., Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., Nuance Communications, Inc., Synopsys Inc., NVIDIA Corporation, Nanox, Butterfly Network, Inc., Hyperfine. Aidoc, Arterys Inc, Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, Envoy AI, MIRADA MEDICAL LIMITED, VUNO Inc., and Zebra Medical Vision, Inc.

Key Questions Answered in this Report:

  • What are the various AI-enabled medical imaging solutions and systems available in the market?
  • What is the current market size and future potential of these products?
  • What are the major market drivers, challenges, and opportunities in the global AI-enabled medical imaging solutions market?
  • What are the guidelines implemented by different government bodies to regulate the approval of AI-enabled medical imaging solutions?
  • What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
  • Who are the leading players holding dominating shares in the global AI-enabled medical imaging solutions market, currently?
  • What are the key strategies incorporated by the players of global AI-enabled medical imaging solutions market, to sustain the competition and retain their supremacy?
  • What is the current revenue contribution of different therapeutic applications, workflow, and modality, and how would it evolve in the forecast period?
  • What is the current demand contribution of different product types and how would it evolve in the forecast period?
  • What is the current demand contribution of different deployment models and how would it evolve in the forecast period?
  • Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global AI-enabled medical imaging solutions market?

Overview on the Global AI-Enabled Medical Imaging Solutions Market

Global AI-enabled imaging modalities market is currently witnessing a significant change in the market landscape. There is rising investment in development of healthcare infrastructure, increasing evidences for efficient and promising results in treatment and diagnosis assistance. Thus, this is leading to potential growth opportunities for the AI-enabled imaging modalities market. Moreover, there is an extensive entry of emerging players developing AI powered imaging systems, and software companies into the healthcare space. All these predominant factors have led to a significant rise in sales of AI-based imaging modality systems across the globe.

Global AI-Enabled Medical Imaging Solutions Market Forecast, 2020-2030

The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020-2030. The increasing complexities in clinical decision making, rising radiologist workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting the market growth. These challenges include the physicians' reluctance toward the adoption of advanced technologies such as AI and the privacy and security concerns related to healthcare data. Hence, it is anticipated that these trends will have a significant impact on AI-enabled medical imaging solutions market in the next five years, and the market will grow multifold.

Competitive Landscape

The global AI-enabled medical imaging solutions market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of AI in healthcare, the manufacturers in the market have ample number of opportunities to expand their offerings and to establish a strong foothold in the market.

During January 2015- November 2020, the market witnessed approximately 134 joint ventures, collaborations, and partnerships, 102 funding and investments, 101 product approvals, 54 product launches and enhancements, and six mergers and acquisitions in the past five years (2015-2020). Joint ventures, collaborations, and partnerships were among the most frequently followed strategies which were incorporated by numerous players to establish a strong foothold in the market.

Most of the manufacturers in the market are incorporating collaborations and partnerships with not only other companies but also the university and research institutions as the key strategies to develop novel AI-embedded medical imaging systems and attain a strong financial position in the market.

Moreover, the leading imaging modality providers in the global AI-enabled medical imaging solutions market include Koninklijke Philips N.V., EchoNous, Inc., 4Dx Limited, Samsung Group, and Butterfly Network, Inc.

The leading platform providers, IT, and computing vendors in the global AI-enabled medical imaging solutions market include Intel Corporation, Blackford Analysis Limited, Synopsys, Inc., edgecase.ai, NTT Data Corporation, and EnvoyAI, among others.

Table of Contents

Executive Summary

1 Product Definition

2 Research Scope

3 Research Methodology

  • 3.1 Primary Research
  • 3.2 Secondary Research
  • 3.3 Data Sources and Categorization
  • 3.4 Criteria for Company Profiles
  • 3.5 Market Estimation and Forecast Methodology
  • 3.6 Data Triangulation
  • 3.7 Assumptions and Limitations

4 Industry Insights

  • 4.1 Industry Ecosystem
  • 4.2 Legal Requirements and Regulations
    • 4.2.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
      • 4.2.1.1 Restraints in Current Regulatory Process for AI/ML-Based Medical Device/Algorithm
    • 4.2.2 Regulatory Framework in the U.S.
    • 4.2.3 Regulatory Framework in Europe
      • 4.2.3.1 Changes in Rule
      • 4.2.3.2 New Rules in the Annexure VIII
      • 4.2.3.3 Major Changes in the EU due to the Implementation of MDR:
        • 4.2.3.3.1 Expanded Device Definitions Requiring Re-Examination of the Current Classification of All Devices
        • 4.2.3.3.2 Quality Management System
        • 4.2.3.3.3 Technical File
        • 4.2.3.3.4 Need to Comply with New Identification and Traceability (UDI) Requirements
        • 4.2.3.3.5 More Emphasis on Post-Market Surveillance
        • 4.2.3.3.6 Need for Strengthening the Role of Internal Audits and Mandatory Audits
        • 4.2.3.3.7 Dedicated Personnel for MDR compliance
    • 4.2.4 Regulatory Framework in Japan
    • 4.2.5 Regulatory Framework in China
    • 4.2.6 Regulatory Framework in Other Countries
      • 4.2.6.1 Regulatory Framework in India
      • 4.2.6.2 Regulatory Framework in Latin America
      • 4.2.6.3 Regulatory Framework in the Middle East and Africa (MEA)
    • 4.2.7 Consortiums, Associations, and Regulatory Bodies
  • 4.3 Impact of COVID-19
    • 4.3.1 Impact on Clinical Settings and Clinical Decision-Making
    • 4.3.2 Impact on AI-Based Medical Imaging Solution Manufacturers
    • 4.3.3 Conclusion

5 Real World Evidence

  • 5.1 Overview
  • 5.2 Aidoc
    • 5.2.1 Role of Aidoc in the Global AI-Enabled Medical Imaging Solutions Market
  • 5.3 Arterys Inc.
    • 5.3.1 Role of Arterys Inc. in the Global AI-Enabled Medical Imaging Solutions Market
  • 5.4 Bay Labs, Inc.
    • 5.4.1 Role of Bay Labs, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
  • 5.5 Heart Flow, Inc.
    • 5.5.1 Role of Heart Flow, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
  • 5.6 MIRADA MEDICAL LIMITED
    • 5.6.1 Role of Mirada Medical Limited in the Global AI-Enabled Medical Imaging Solutions Market
  • 5.7 RADLogics Inc.
    • 5.7.1 Role of RADLogics Inc. in the Global AI-Enabled Medical Imaging Solutions Market
  • 5.8 VIDA Diagnostics, Inc.
    • 5.8.1 Role of VIDA Diagnostics, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
  • 5.9 VUNO Inc.
    • 5.9.1 Role of VUNO lnc. in the Global AI-Enabled Medical Imaging Solutions Market
  • 5.1 Zebra Medical Vision, Inc.
    • 5.10.1 Role of Zebra Medical Vision, Inc. in the Global AI-Enabled Medical Imaging Solutions Market

6 Global AI-Enabled Medical Imaging Solutions Market Scenario

  • 6.1 Assumptions and Limitations
  • 6.2 Global Market Scenario
  • 6.3 Potential Market Opportunities
    • 6.3.1 Rapidly Evolving Deep Learning Techniques
    • 6.3.2 Increasing Number of Cross-Industry Partnerships
  • 6.4 Market Dynamics
    • 6.4.1 Impact Analysis
    • 6.4.2 Market Drivers
      • 6.4.2.1 Increasing Complexities of Clinical Decision-Making
      • 6.4.2.2 Expanding Range of Applications
      • 6.4.2.3 Shortage of Healthcare Workforce
      • 6.4.2.4 Huge R&D Investments
    • 6.4.3 Market Restraints
      • 6.4.3.1 Privacy and Security Concerns Related to Healthcare Data
      • 6.4.3.2 Regulatory Challenges
      • 6.4.3.3 Barriers to Physician's Adoption of AI
      • 6.4.3.4 Lag in Regulatory Approvals
      • 6.4.3.5 Legal Implications of AI Systems
      • 6.4.3.6 Rise in Medical Imaging Expenses
      • 6.4.3.7 Data Security and Privacy Issues
      • 6.4.3.8 Lack of Trained Staff

7 Competitive Landscape

  • 7.1 Key Strategies and Developments
    • 7.1.1 Joint Ventures, Collaborations, and Partnerships
    • 7.1.2 Funding and Investments
    • 7.1.3 Regulatory and Legal Activities.
      • 7.1.3.1 U.S. FDA Approvals
      • 7.1.3.2 CE Mark Approvals
      • 7.1.3.3 PMDA Approvals
      • 7.1.3.4 Others
    • 7.1.4 Product Launches and Enhancements
    • 7.1.5 Mergers and Acquisitions
  • 7.2 Growth Share Analysis
    • 7.2.1 Growth Share Matrix (by Product)
    • 7.2.2 Growth Share Matrix (by Workflow)
    • 7.2.3 Growth Share Matrix (by Modality)

8 Global AI-Enabled Medical Imaging Solutions Market (by Modality)

  • 8.1 Overview
  • 8.2 Computed Tomography (CT)
  • 8.3 Magnetic Resonance (MR)
  • 8.4 Ultrasound
  • 8.5 X-Ray
  • 8.6 Mammography
  • 8.7 Multimodality Imaging Systems
  • 8.8 Other Modalities

9 Global AI-Enabled Medical Imaging Solutions Market (by Product)

  • 9.1 Overview
  • 9.2 Software
    • 9.2.1 Perpetual Software License
    • 9.2.2 Subscription Software License
    • 9.2.3 Fee-Per Case Software License
  • 9.3 Hardware

10 Global AI-Enabled Medical Imaging Solutions Market (by Deployment Model)

  • 10.1 Overview
  • 10.2 Cloud- and Web-Based Solutions
  • 10.3 On-Premises Solutions

11 Global AI-Enabled Medical Imaging Solutions Market (by Workflow), 2019-2030

  • 11.1 Overview
  • 11.2 Image Acquisition
  • 11.3 Image Analysis
  • 11.4 Detection
  • 11.5 Diagnosis and Treatment Decision Support
  • 11.6 Predictive Analysis and Risk Assessment
  • 11.7 Triage
  • 11.8 Reporting and Communication

12 Global AI-Enabled Medical Imaging Solutions Market (by Therapeutic Application)

  • 12.1 Overview
  • 12.2 Specialty Imaging
    • 12.2.1 Cardiology
    • 12.2.2 Oncology
      • 12.2.2.1 Lung Cancer
      • 12.2.2.2 Breast Cancer
      • 12.2.2.3 Other Cancer Types
    • 12.2.3 Neurology
    • 12.2.4 Respiratory
    • 12.2.5 Orthopedics
    • 12.2.6 Others
  • 12.3 General Imaging

13 Global AI-Enabled Medical Imaging Solutions Market (by Region)

  • 13.1 Overview
  • 13.2 North America
    • 13.2.1 Market Footprint: North America AI-Enabled Medical Imaging Solutions Market
    • 13.2.2 North America AI-Enabled Medical Imaging Solutions Market (by Country)
      • 13.2.2.1 U.S.
      • 13.2.2.2 Canada
  • 13.3 Europe
    • 13.3.1 Market Footprint: Europe AI-Enabled Medical Imaging Solutions Market
    • 13.3.2 Europe AI-Enabled Imaging Medical Imaging Solutions Market (by Country)
      • 13.3.2.1 U.K.
      • 13.3.2.2 Germany
      • 13.3.2.3 France
      • 13.3.2.4 Spain
      • 13.3.2.5 Italy
      • 13.3.2.6 Rest-of-Europe
      • 13.3.2.7 Switzerland
      • 13.3.2.8 Sweden
      • 13.3.2.9 Netherlands
  • 13.4 Asia-Pacific
    • 13.4.1 Market Footprint: Asia-Pacific AI-Enabled Medical Imaging Solutions Market
    • 13.4.2 Asia-Pacific AI-Enabled Medical Imaging Solutions Market (by Country)
      • 13.4.2.1 China
      • 13.4.2.2 Japan
      • 13.4.2.3 Australia and New Zealand
      • 13.4.2.4 South Korea
      • 13.4.2.5 Singapore
      • 13.4.2.6 Rest-of-Asia-Pacific
  • 13.5 Rest-of-the-World (RoW)
    • 13.5.1 Market Footprint: Rest-of-the-World AI-Enabled Medical Imaging Solutions Market

14 Company Profiles

  • 14.1 Overview
  • 14.2 Agfa-Gevaert Group
    • 14.2.1 Company Overview
    • 14.2.2 Role of Agfa-Gevaert Group in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.2.3 Financials
    • 14.2.4 Agfa-Gevaert Group: SWOT Analysis
  • 14.3 Butterfly Network, Inc.
    • 14.3.1 Company Overview
    • 14.3.2 Role of Butterfly Network, Inc. in the Global AI-Enabled Imaging Solutions Market
    • 14.3.3 Butterfly Network, Inc.: SWOT Analysis
  • 14.4 Fujifilm Holdings Corporation
    • 14.4.1 Company Overview
    • 14.4.2 Role of Fujifilm Holdings Corporation in the Global AI-Enabled Imaging Solutions Market
    • 14.4.3 Financials
      • 14.4.3.1 Key Insights About the Financial Health of the Company
    • 14.4.4 Fujifilm Holdings Corporation: SWOT Analysis
  • 14.5 General Electric Company
    • 14.5.1 Company Overview
    • 14.5.2 Role of General Electric Company in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.5.3 Financials
      • 14.5.3.1 Key Insights About the Financial Health of the Company
    • 14.5.4 General Electric Company: SWOT Analysis
  • 14.6 Hyperfine
    • 14.6.1 Company Overview
    • 14.6.2 Role of Hyperfine in the Global AI-Enabled Imaging Solutions Market
    • 14.6.3 Hyperfine: SWOT Analysis
  • 14.7 Hologic, Inc.
    • 14.7.1 Company Overview
    • 14.7.2 Role of Hologic, Inc. in the Global AI-Enabled Imaging Solutions Market
    • 14.7.3 Financials
    • 14.7.4 Hologic, Inc.: SWOT Analysis
  • 14.8 Koninklije Philips N.V.
    • 14.8.1 Company Overview
    • 14.8.2 Role of Koninklijke Philips N.V. in the Global AI-Enabled Imaging Solutions Market
    • 14.8.3 Financials
      • 14.8.3.1 Key Insights About the Financial Health of the Company
    • 14.8.4 Koninklijke Philips N.V.: SWOT Analysis
  • 14.9 Nanox
    • 14.9.1 Company Overview
    • 14.9.2 Role of Nanox in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.9.3 SWOT Analysis: Nanox
  • 14.1 Siemens Healthineers AG
    • 14.10.1 Company Overview
    • 14.10.2 Role of Siemens Healthineers AG in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.10.3 Financials
      • 14.10.3.1 Key Insights About the Financial Health of the Company
    • 14.10.4 Siemens Healthineers AG: SWOT Analysis
  • 14.11 Aidoc
    • 14.11.1 Company Overview
    • 14.11.2 Role of Aidoc in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.11.3 SWOT Analysis: Aidoc
  • 14.12 Arterys Inc.
    • 14.12.1 Company Overview
    • 14.12.2 Role of Arterys Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.12.3 SWOT Analysis: Arterys Inc.
  • 14.13 Beijing Infervision Technology Co., Ltd.
    • 14.13.1 Company Overview
    • 14.13.2 Role of Beijing Infervision Technology Co., Ltd. in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.13.3 SWOT Analysis: Beijing Infervision Technology Co., Ltd.
  • 14.14 Blackford Analysis Limited
    • 14.14.1 Company Overview
    • 14.14.2 Role of Blackford Analysis Limited in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.14.3 SWOT Analysis: Blackford Analysis Limited
  • 14.15 Eureka Clinical AI, formerly known as EnvoyAI
    • 14.15.1 Company Overview
    • 14.15.2 Role of Eureka Clinical AI, formerly known as EnvoyAI in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.15.3 SWOT Analysis: EnvoyAI
  • 14.16 iCAD, Inc.
    • 14.16.1 Company Overview
    • 14.16.2 Role of iCAD, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.16.3 Financials
      • 14.16.3.1 Key Insights About the Financial Health of the Company
    • 14.16.4 iCAD, Inc.: SWOT Analysis
  • 14.17 MIRADA MEDICAL LIMITED
    • 14.17.1 Company Overview
    • 14.17.2 Role of MIRADA MEDICAL LIMITED in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.17.3 SWOT Analysis: MIRADA MEDICAL LIMITED
  • 14.18 Nuance Communications, Inc.
    • 14.18.1 Company overview
    • 14.18.2 Role of Nuance Communications, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.18.3 Financials
      • 14.18.3.1 Key Insights About the Financial Health of the Company
    • 14.18.4 Nuance Communications, Inc.: SWOT Analysis
  • 14.19 NVIDIA Corporation
    • 14.19.1 Company overview
    • 14.19.2 Role of NVIDIA Corporation in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.19.3 Financials
      • 14.19.3.1 Key Insights About the Financial Health of the Company
    • 14.19.4 NVIDIA Corporation: SWOT Analysis
  • 14.2 Synopsys, Inc.
    • 14.20.1 Company Overview
    • 14.20.2 Role of Synopsys, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.20.3 Financials
      • 14.20.3.1 Key Insights About the Financial Health of the Company
    • 14.20.4 Synopsys, Inc.: SWOT Analysis
  • 14.21 VUNO lnc.
    • 14.21.1 Company Overview
    • 14.21.2 Role of VUNO lnc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.21.3 SWOT Analysis: VUNO lnc.
  • 14.22 Zebra Medical Vision, Inc.
    • 14.22.1 Company Overview
    • 14.22.2 Role of Zebra Medical Vision, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 14.22.3 SWOT Analysis: Zebra Medical Vision, Inc.

List of Tables

  • Table 1: Market Drivers
  • Table 2: Market Restraints
  • Table 4.1: Database of the FDA-Approved AI/ML-Based Medical Devices and Algorithms
  • Table 4.2: List of Associations/Consortiums/Regulatory Bodies with Year of Establishment and Region
  • Table 5.1: Improvement in the RTAT of the Head and Neck CT Scans from Various Algorithms as Compared to the FIFO Concept
  • Table 5.2: Cost Comparison: Standard Care vs. VIDAvision
  • Table 6.1: Market Drivers
  • Table 6.2: Market Restraints
  • Table 7.1: List of FDA Approvals, January 2015-November 2020
  • Table 7.2: List of CE Mark Approvals, January 2015-November 2020
  • Table 7.3: List of Other Approvals, January 2015-November 2020
  • Table 8.1: List of Recently Approved AI-Enabled Mammography Solutions

List of Figures

  • Figure 1: Applications of AI in Healthcare
  • Figure 2: Share of Key Developments and Strategies, January 2015 - November 2020
  • Figure 3: Global AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 4: Global AI-Enabled Medical Imaging Solutions Market Share (by Product), 2019 and 2030
  • Figure 5: Global AI-Enabled Medical Imaging Solutions Market Share (by Workflow), 2019 and 2030
  • Figure 6: Global AI-Enabled Medical Imaging Solutions Market Share (by Therapeutic Application), 2019 and 2030
  • Figure 7: Global AI-Enabled Medical Imaging Solutions Market Share (by Deployment Model), 2019 and 2030
  • Figure 8: Global AI-Enabled Medical Imaging Solutions Market Share (by Modality), 2019 and 2030
  • Figure 9: Global AI-Enabled Medical Imaging Solutions Market Regional Snapshot, 2019 and 2030
  • Figure 2.1: Global AI-Enabled Medical Imaging Solutions Market Segmentation
  • Figure 3.1: Research Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Assumptions and Limitations
  • Figure 4.1: Industry Ecosystem
  • Figure 4.2: Regulatory Process for Medical Devices in the U.S.
  • Figure 4.3: MDR Transitional Provisions
  • Figure 4.4: MDR Timeline
  • Figure 5.1: Aidoc Product Offerings
  • Figure 5.2: Average RTAT for Positive Studies for AI-based Prioritized Queue and Baseline
  • Figure 5.3: Arterys Inc. Product Offerings
  • Figure 5.4: Cardiac Ejection Fraction Measurement: Conventional vs. CardioAI
  • Figure 5.5: Bay Labs, Inc. Product Offerings
  • Figure 5.6: Difference Between the Average Variability of the Cardiologists as Compared with the Variability of EchoMD AutoEF
  • Figure 5.7: Heart Flow, Inc. Product Offerings
  • Figure 5.8: Cost Reduction: Standard Treatment vs. HeartFlow FFRCT Analysis
  • Figure 5.9: Mirada Medical Limited Product Offerings
  • Figure 5.10: Comparison of DLCExpert Contours vs. Clinical Contours
  • Figure 5.11: RADLogics Inc. Product Offerings
  • Figure 5.12: Chest CT Time Reduction Using Virtual-Resident
  • Figure 5.13: VIDA Diagnostics Inc. Product Offerings
  • Figure 5.14: VUNO Inc. Product Offerings
  • Figure 5.15: Accuracy: BoneAge vs. Physician
  • Figure 5.16: Time: BoneAge vs. Physician
  • Figure 5.17: Zebra Medical Vision, Inc. Product Offerings
  • Figure 5.18: Algorithm-Radiologists Agreement as Compared to the Inter-Radiologists Agreement when the Algorithm Results are not Shown
  • Figure 5.19: Algorithm-Radiologists Agreement as Compared to the Inter-Radiologists Agreement when the Algorithm Results are Shown
  • Figure 6.1: Global AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 6.2: Top Ten Findings in Global AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 7.1: Share of Key Developments and Strategies, January 2015-November 2020
  • Figure 7.2: Share of Joint Ventures, Collaborations, and Partnerships, January 2015-November 2020
  • Figure 7.3: Major Joint Ventures, Collaborations, and Partnerships: General Electric Company
  • Figure 7.4: Major Joint Ventures, Collaborations, and Partnerships: Siemens Healthineers AG
  • Figure 7.5: Share of Product Launches and Enhancements, January 2015-November 2020
  • Figure 7.6: Share of Mergers and Acquisitions, January 2015-November 2020
  • Figure 7.7: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Product), 2019-2030
  • Figure 7.8: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Workflow), 2019-2030
  • Figure 7.9: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Modality), 2019-2030
  • Figure 8.1: Global AI-Enabled Medical Imaging Solutions Market (by Modality), 2019-2030
  • Figure 8.2: Global AI-Enabled Medical Imaging Solutions Market (CT), 2019-2030
  • Figure 8.3: Global AI- Medical Imaging Solutions Market (Magnetic Resonance), 2019-2030
  • Figure 8.4: Global AI-Enabled Medical Imaging Solutions Market (Ultrasound), 2019-2030
  • Figure 8.5: Global AI-Enabled Medical Imaging Solutions Market (X-Ray), $Million, 2019-2030
  • Figure 8.6: Global AI-Enabled Medical Imaging Solutions Market (Mammography), 2019-2030
  • Figure 8.7: Global AI-Enabled Medical Imaging Solutions Market (Multimodality Imaging Systems), 2019-2030
  • Figure 8.8: Global AI-Enabled Medical Imaging Solutions Market (Other Modalities), 2019-2030
  • Figure 9.1: Global AI-Enabled Medical Imaging Solutions Market (by Product), 2019-2030
  • Figure 9.2: Global AI-Enabled Medical Imaging Solutions Market (by Software), 2019-2030
  • Figure 9.3: Global AI-Enabled Medical Imaging Solutions Market (Perpetual Software License), 2019-2030
  • Figure 9.4: Global AI-Enabled Medical Imaging Solutions Market (Subscription Software License), 2019-2030
  • Figure 9.5: Global AI-Enabled Medical Imaging Solutions Market (Fee-Per Case Software License), 2019-2030
  • Figure 9.6: Global AI-Enabled Medical Imaging Solutions Market (Hardware), 2019-2030
  • Figure 10.1: Global AI-Enabled Medical Imaging Solutions Market (by Deployment Model), 2019-2030
  • Figure 10.2: Global AI-Enabled Medical Imaging Solutions Market (by Cloud and Web-Based Solutions), 2019-2030
  • Figure 10.3: Global AI-Enabled Medical Imaging Solutions Market (by On-Premises Solutions), 2019-2030
  • Figure 11.1: Global AI-Enabled Medical Imaging Solutions Market (Image Acquisition), 2019-2030
  • Figure 11.2: Global AI-Enabled Medical Imaging Solutions Market (Image Analysis), 2019-2030
  • Figure 11.3: Global AI-Enabled Medical Imaging Solutions Market (Detection), 2019-2030
  • Figure 11.4: Global AI-Enabled Medical Imaging Solutions Market (Diagnosis and Treatment Decision Support), 2019-2030
  • Figure 11.5: Global AI-Enabled Medical Imaging Solutions Market (Predictive Analysis and Risk Assessment), 2019-2030
  • Figure 11.6: Global AI-Enabled Medical Imaging Solutions Market (Triage), 2019-2030
  • Figure 11.7: Global AI-Enabled Medical Imaging Solutions Market (Reporting and Communication), 2019-2030
  • Figure 12.1: Global AI-Enabled Medical Imaging Solutions Market (by Therapeutic Application), 2019-2030
  • Figure 12.2: Global AI-Enabled Medical Imaging Solutions Market (Specialty Imaging), 2019-2030
  • Figure 12.3: Global AI-Enabled Medical Imaging Solutions Market (Cardiology), 2019-2030
  • Figure 12.4: Applications of AI in Cancer Imaging
  • Figure 12.5: Global AI-Enabled Medical Imaging Solutions Market (Oncology), 2019-2030
  • Figure 12.6: Global AI-Enabled Medical Imaging Solutions Market (Lung Cancer), 2019-2030
  • Figure 12.7: Global AI-Enabled Medical Imaging Solutions Market (Breast Cancer), 2019-2030
  • Figure 12.8: Global AI-Enabled Medical Imaging Solutions Market (by Other Cancer Types), 2019-2030
  • Figure 12.9: Global AI-Enabled Medical Imaging Solutions Market (Neurology), 2019-2030
  • Figure 12.10: Global AI-Enabled Medical Imaging Solutions Market (Respiratory), 2019-2030
  • Figure 12.11: Global AI-Enabled Medical Imaging Solutions Market (Orthopedics), 2019-2030
  • Figure 12.12: Global AI-Enabled Medical Imaging Solutions Market (Others), 2019-2030
  • Figure 12.13: Global AI-Enabled Medical Imaging Solutions Market (General Imaging), 2019-2030
  • Figure 13.1: Global AI-Enabled Medical Imaging Solutions Market Scenario, 2019 and 2030
  • Figure 13.2: North America AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.3: North America AI-Enabled Medical Imaging Solutions Market: Market Dynamics
  • Figure 13.4: North America AI-Enabled Medical Imaging Solutions Market (by Country), 2019-2030
  • Figure 13.5: U.S. AI-Enabled Imaging Medical Imaging Solutions Market, 2019-2030
  • Figure 13.6: Canada AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.7: Europe AI-Enabled Imaging Medical Imaging Solutions Market, 2019-2030
  • Figure 13.8: Europe AI-Enabled Medical Imaging Solutions Market: Market Dynamics
  • Figure 13.9: Europe AI-Enabled Medical Imaging Solutions Market (by Country), 2019-2030
  • Figure 13.10: U.K. AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.11: Germany AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.12: France AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.13: Spain AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.14: Italy AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.15: Rest-of-Europe AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.16: Switzerland AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.17: Sweden AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.18: Netherlands AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.19: Asia-Pacific AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.20: Asia-Pacific AI-Enabled Medical Imaging Solutions Market: Market Dynamics
  • Figure 13.21: Asia-Pacific AI-Enabled Medical Imaging Solutions Market (by Country), 2019-2030
  • Figure 13.22: China AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.23: Japan AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.24: Australia and New Zealand AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.25: South Korea AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.26: Singapore AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.27: Rest-of-Asia-Pacific AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 13.28: Rest-of-the-World AI-Enabled Medical Imaging Solutions Market, 2019-2030
  • Figure 14.1: Shares of Key Company Profiles
  • Figure 14.2: Agfa-Gevaert Group: Product Offerings for the Global AI-Enabled Imaging Solutions Market
  • Figure 14.3: Agfa-Gevaert Group: Overall Financials, 2017-2019
  • Figure 14.4: Agfa-Gevaert Group: Net Revenue (by Business Segment), 2017-2019
  • Figure 14.5: Agfa-Gevaert Group: Revenue (by Region), 2017-2019
  • Figure 14.6: Agfa-Gevaert Group: R&D Expenditure, 2017-2019
  • Figure 14.7: Butterfly Network, Inc.: Product Offerings for the Global AI-Enabled Imaging Solutions Market
  • Figure 14.8: Fujifilm Holdings Corporation: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.9: Fujifilm Holdings Corporation: Overall Financials, 2017-2019
  • Figure 14.10: Fujifilm Holdings Corporation Net Revenue (by Business Segment), 2017-2019
  • Figure 14.11: Fujifilm Holdings Corporation: Net Revenue (by Region), 2016-2018
  • Figure 14.12: Fujifilm Holdings Corporation: R&D Expense, 2017-2019
  • Figure 14.13: General Electric Company: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.14: General Electric Company: Overall Financials, 2017-2019
  • Figure 14.15: General Electric Company Net Revenue (by Business Segment), 2017-2019
  • Figure 14.16: General Electric Company: Net Revenue (by Region), 2017-2019
  • Figure 14.17: General Electric Company: R&D Expenditure, 2017-2019
  • Figure 14.18: Hyperfine: Product Offerings for the AI-Enabled Imaging Solutions Market
  • Figure 14.19: Hologic, Inc.: Product Offerings for the AI-Enabled Imaging Solutions Market
  • Figure 14.20: Hologic, Inc.: Overall Financials, 2017-2019
  • Figure 14.21: Hologic, Inc.: Net Revenue (by Business Segment), 2017-2019
  • Figure 14.22: Hologic, Inc.: Revenue (by Region), 2017-2019
  • Figure 14.23: Hologic, Inc.: R&D Expenditure, 2017-2019
  • Figure 14.24: Koninklijke Philips N.V.: Product Offerings for the Global AI-Enabled Imaging Solutions Market
  • Figure 14.25: Koninklijke Philips N.V.: Overall Financials, 2017-2019
  • Figure 14.26: Koninklijke Philips N.V. Net Revenue (by Business Segment), 2017-2019
  • Figure 14.27: Koninklijke Philips N.V.: Net Revenue (by Region), 2017-2019
  • Figure 14.28: Koninklijke Philips N.V.: R&D Expenditure, 2017-2019
  • Figure 14.29: Nanox: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.30: Siemens Healthineers AG: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.31: Siemens Healthineers AG: Overall Financials, 2018-2020
  • Figure 14.32: Siemens Healthineers AG Net Revenue (by Business Segment), 2018-2020
  • Figure 14.33: Siemens Healthineers AG: Net Revenue (by Region), 2018-2020
  • Figure 14.34: Siemens Healthineers AG: R&D Expenditure, 2018-2020
  • Figure 14.35: Aidoc: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.36: Arterys Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.37: Beijing Infervision Technology Co., Ltd.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.38: Blackford Analysis Limited: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.39: EnvoyAI: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.40: iCAD, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.41: iCAD, Inc.: Overall Financials, 2017-2019
  • Figure 14.42: iCAD, Inc. Net Revenue (by Business Segment), 2017-2019
  • Figure 14.43: iCAD, Inc.: R&D Expense, 2017-2019
  • Figure 14.44: MIRADA MEDICAL LIMITED: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.45: Nuance Communications, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.46: Nuance Communications, Inc.: Overall Financials, 2018-2020
  • Figure 14.47: Nuance Communications, Inc. Net Revenue (by Business Segment), 2018-2020
  • Figure 14.48: Nuance Communications, Inc.: R&D Expense, 2018-2020
  • Figure 14.49: NVIDIA Corporation: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.50: NVIDIA Corporation: Overall Financials, 2017-2019
  • Figure 14.51: NVIDIA Corporation Net Revenue (by Business Segment), 2017-2019
  • Figure 14.52: NVIDIA Corporation: Net Revenue (by Region), 2017-2019
  • Figure 14.53: NVIDIA Corporation: R&D Expense, 2017-2019
  • Figure 14.54: Synopsys, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.55: Synopsys, Inc.: Overall Financials, 2018-2020
  • Figure 14.56: Synopsys, Inc.: Net Revenue (by Region), 2018-2020
  • Figure 14.57: Synopsys, Inc.: R&D Expense, 2018-2020
  • Figure 14.58: VUNO lnc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 14.59: Zebra Medical Vision, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market